EOG
56
-2
XYL
35
-2
NOV
52
-5
EIX
70
3
KSS
39
-7
GD
41
-4
HPE
44
-2
EFX
30
-8
TDC
67
-4
WM
74
-5
GME
66
-5
INTC
41
4
EQR
54
3
FE
44
5
EXR
57
2
PEG
62
4
UPS
48
2
SCHW
62
-2
TGT
45
-4
MSFT
48
-9
EOG
56
-2
XYL
35
-2
NOV
52
-5
EIX
70
3
KSS
39
-7
GD
41
-4
HPE
44
-2
EFX
30
-8
TDC
67
-4
WM
74
-5
GME
66
-5
INTC
41
4
EQR
54
3
FE
44
5
EXR
57
2
PEG
62
4
UPS
48
2
SCHW
62
-2
TGT
45
-4
MSFT
48
-9
Financhill
Back

First Trust Core Investment Grade ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
13

FTCB
First Trust Core Investment Grade ETF

Last Price:
20.85
Seasonality Move:
4.91%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
13
First Trust Core Investment Grade ETF (FTCB) is a Sell

Is First Trust Core Investment Grade ETF a Buy, Sell or Hold?

  • The current First Trust Core Investment Grade ETF [FTCB] share price is $20.79. The Score for FTCB is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • FTCB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FTCB Stock Price Chart

What is First Trust Core Investment Grade ETF's stock price today?

  • The First Trust Core Investment Grade ETF share price today is $20.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTCB is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FTCB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 34.6 Sell
Chaikin Money Flow: -403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.8 - 21.16) Sell
Bollinger Bands (100): (20.91 - 21.57) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FTCB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.85 Sell
20-day SMA: 20.9 Sell
50-day SMA: 21.29 Sell
200-day SMA: 20.98 Sell
8-day EMA: 20.84 Sell
20-day EMA: 20.94 Sell
50-day EMA: 21.12 Sell
200-day EMA: 21.02 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Trust Core Investment Grade ETF Earnings Growth & FTCB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

First Trust Core Investment Grade ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):